跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ABISART HCTZ 300/25 irbesartan 300 mg + hydrochlorothiazide 25 mg tablet blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
ABISART HCTZ 300/25 irbesartan 300 mg + hydrochlorothiazide 25 mg tablet blister pack
Approved
STANDARD
ABISART HCTZ 300/25 irbesartan 300 mg + hydrochlorothiazide 25 mg tablet blister pack
Sun Pharma ANZ Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
015384c1eef51e85
Company
Sun Pharma ANZ Pty Ltd
Type
Standard
Approval Details
Approval Id
015384c1eef51e85
Product Name
ABISART HCTZ 300/25 irbesartan 300 mg + hydrochlorothiazide 25 mg tablet blister pack
Artg Id
302149
Artg Name
ABISART HCTZ 300/25 irbesartan 300 mg + hydrochlorothiazide 25 mg tablet blister pack
Sponsor
Sun Pharma ANZ Pty Ltd
Company Detail Path
/organization/sun-pharma-anz-pty-ltd
Artg Date
2018-11-06
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/936b31b4c1cd25b32207aa5c8e68e10a.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/fb0e8e668845e7f57cbf1838e78c695d.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
015384c1eef51e85
Type
Standard
Back to TGA Approvals